Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects from 6 Months of Age

Trial Identifier: FSQ02
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: January 2020
Primary Completion Date: December 2020
Study Completion Date: December 2020
Condition: Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
CHINA Kunming, CHINA, 650022
CHINA Lincang, CHINA, 677001
CHINA Shangqiu, CHINA, 476000
CHINA Xinxiang, CHINA, 453200
CHINA Zhengzhou, CHINA, 450002